Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 9/20 | 0.49 |
| ▸ | DRD3 | P35462 | 7/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 8/20 | 0.42 |
| ▸ | HTR2A | P28223 | 8/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1840347 | 0.80 | DRD2 (0.58) | DRD2DRD3DRD4GRM2HTR1A | |
| SCHEMBL21633611 | 0.79 | GPR119 (0.49) | DRD2DRD3DRD4GRM2HTR1A | |
| Bromide SCHEMBL10365464 | 0.79 | DRD2 (0.57) | DRD2DRD3DRD4GRM2HTR1A | |
| Hydrochloric Acid SCHEMBL1836699 | 0.79 | DRD2 (0.57) | DRD2DRD3DRD4GRM2HTR1A | |
| SCHEMBL10991961 | 0.77 | DRD2 (0.52) | DRD2DRD3DRD4GRM2HTR1A | |
| SCHEMBL10364952 | 0.76 | DRD2 (0.57) | DRD2DRD3DRD4GRM2HTR1A | |
| SCHEMBL24045832 | 0.76 | KDM4E (0.56) | DRD2DRD3HTR1AHTR2AKDM4E | |
| SCHEMBL10365473 | 0.75 | DRD2 (0.43) | DRD2DRD3DRD4GRM2HTR1A | |
| SCHEMBL10987775 | 0.75 | GRM4 (0.55) | DRD2DRD3DRD4GRM2HTR1A | |
| Bromide SCHEMBL10365633 | 0.75 | DRD2 (0.56) | DRD2DRD3DRD4GRM2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912647-B2 | Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11912647-B2 | Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20210363098-A1 | DIVERSITY-ORIENTED SYNTHESIS OF N,N,O-TRISUBSTITUTED HYDROXYLAMINES FROM ALCOHOLS AND AMINES BY N-O BOND FORMATION | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2021-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363098-A1 | DIVERSITY-ORIENTED SYNTHESIS OF N,N,O-TRISUBSTITUTED HYDROXYLAMINES FROM ALCOHOLS AND AMINES BY N-O BOND FORMATION | ADH5, ADH1A, NAT1 | DRD2 118/4885DRD3 160/4885DRD4 235/4885 |
| US-11912647-B2 | Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation | ADH5, ADH1A, NAT1 | DRD2 102/4885DRD3 149/4885DRD4 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.